Evidence map›Paper›PMID 33646175›Full record

ArticleJournal of neuromuscular diseases2021

Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era.

Maggie C Walter, Claudia Chiriboga, Tina Duong, Nathalie Goemans, Anna Mayhew, Laëtitia Ouillade, Maryam Oskoui, Ros Quinlivan, Juan F Vázquez-Costa, John Vissing and 1 more

Open access · bronzeAbstract readLetter
In one paragraph

Article in Journal of neuromuscular diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Oral function tests in spinal muscular atrophy: closing the diagnostic gap in severely affected adult patients : A prospective observational study.Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie · 2026
    Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 9 countries.

Maggie C WalterFriedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany.
Claudia ChiribogaDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Tina DuongStanford University, Stanford, CA, United States.
Nathalie GoemansFaculty of Medicine, University of Leuven, University Hospitals Leuven, Leuven, Belgium.
Anna MayhewNewcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
Laëtitia OuilladeAFM Téléthon, European Patients' Forum Young Patient.
Maryam OskouiDepartments of Pediatrics and Neurology, McGill University, Montreal, QC, Canada.
Ros QuinlivanMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
Juan F Vázquez-CostaMotor Neuron Disease Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
John VissingCopenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Laurent ServaisMDUK Neuromuscular Center, Department of Paediatrics, University of Oxford, Oxford, UK.
Association Francaise contre les Myopathies · FRColumbia University Irving Medical Center · USHospital Universitari i Politècnic La Fe · ESKU Leuven · BELudwig-Maximilians-Universität München · DEMcGill University · CANational Hospital for Neurology and Neurosurgery · GBNewcastle University · GBStanford University · USUniversity of Copenhagen · DKUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While Spinal Muscular Atrophy (SMA) has historically been managed with supportive measures, the emergence of innovative medicines has given those living with SMA hope for improved quality of life and has revolutionized care. Despite these advances, the use of therapies and changes in disease management strategies have focused on pediatric populations, leaving adults living with SMA, and those transitioning into adulthood, relatively neglected. Through a multi-faceted approach that gathered unbiased perspectives from clinical experts, validated insights from individuals with lived experiences, and substantiated findings with evidence from the literature, we have exposed unmet needs that are hindering the field and, ultimately, impacting care and quality of life for adults living with SMA. Here, we set new aspirations and calls to action to inspire continued research in this field, stimulate dialogue across the SMA community and inform policies that deliver effective management and care throughout an adult's journey living with SMA.

Indexed as

Patient ParticipationCost of IllnessHumansMuscular Atrophy, SpinalQuality ImprovementQuality of LifeAdults living with SMABurden of Disease (BoD)health serviceslived experienceNeuromuscular Disease (NMD)Quality of Life (QoL)Spinal Muscular Atrophy (SMA)transition

Identifiers

PMID33646175
PMCPMC8385518
OpenAlexW3133945301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.